Galil Medical

Galil Medical is a global leader in the development and manufacturing of innovative cryotherapy solutions for the treatment of various cancers and benign conditions. The company specializes in cryoablation systems that utilize extremely cold temperatures to precisely destroy targeted tissue while sparing surrounding healthy structures. Its flagship product, the Visual-ICE Cryoablation System, is widely used in interventional oncology and urology for treating tumors in the kidney, prostate, liver, and lungs. Originally founded in Israel and later headquartered in the United States, the company was acquired by BTG plc in 2016 and subsequently became part of Boston Scientific. Galil Medical's technology remains a standard of care in minimally invasive thermal ablation.